Renaissance Capital LLC Sells 46,694 Shares of Tempus AI, Inc. $TEM

Key Points

• Renaissance Capital LLC sold 46,694 shares of Tempus AI, reducing its stake in the company by 41.3% during the second quarter, retaining 66,300 shares valued at approximately $4.2 million.
• CEO Eric P. Lefkofsky sold 332,500 shares at about $76.56 per share, decreasing his ownership by 3.51% and leaving him with over $699 million in Tempus AI stock.
• Tempus AI's stock currently holds a consensus rating of "Moderate Buy" with a price target of $71.83, supported by seven buy ratings and six hold ratings from various analysts.

Renaissance Capital LLC reduced its stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 41.3% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 66,300 shares of the company's stock after selling 46,694 shares during the period. Tempus AI accounts for approximately 2.9% of Renaissance Capital LLC's holdings, making the stock its 14th largest holding. Renaissance Capital LLC's holdings in Tempus AI were worth $4,213,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Cherry Tree Wealth Management LLC bought a new position in Tempus AI in the first quarter valued at approximately $31,000. University of Texas Texas AM Investment Management Co. bought a new stake in Tempus AI during the first quarter worth $33,000. Continuum Advisory LLC bought a new stake in shares of Tempus AI in the 1st quarter valued at about $39,000. Bartlett & CO. Wealth Management LLC raised its stake in Tempus AI by 100.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after acquiring an additional 400 shares during the period. Finally, Nemes Rush Group LLC bought a new position in shares of Tempus AI in the first quarter valued at about $39,000. 24.22% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. Piper Sandler reaffirmed a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Bank of America boosted their target price on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. Morgan Stanley upped their target price on Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a report on Tuesday, August 12th. BTIG Research upped their target price on Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research report on Wednesday, August 20th. Finally, Needham & Company LLC restated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research note on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $71.83.

Insider Buying and Selling at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 332,500 shares of the company's stock in a transaction on Thursday, September 25th. The stock was sold at an average price of $76.56, for a total transaction of $25,456,200.00. Following the transaction, the chief executive officer directly owned 9,141,032 shares of the company's stock, valued at $699,837,409.92. This represents a 3.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Erik Phelps sold 3,664 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $273,517.60. Following the transaction, the executive vice president directly owned 94,115 shares in the company, valued at $7,025,684.75. The trade was a 3.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 933,662 shares of company stock valued at $67,909,393 over the last three months. 26.27% of the stock is currently owned by corporate insiders.

Tempus AI Stock Up 0.1%

TEM opened at $78.57 on Tuesday. Tempus AI, Inc. has a 52 week low of $31.36 and a 52 week high of $97.79. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. The business's fifty day simple moving average is $73.06 and its 200 day simple moving average is $62.29. The stock has a market cap of $13.65 billion, a PE ratio of -66.03 and a beta of 5.08.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. The business had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.Tempus AI's revenue for the quarter was up 89.5% compared to the same quarter last year. During the same period last year, the company earned ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. As a group, research analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.